Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
/Free Sign Up
 Investing Pro 0
💎 Reveal Undervalued Stocks Hiding in Any Market Get Started
Close

Novo Nordisk A/S Class B (0QIU)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
1,081.20 +9.60    +0.90%
03:59:11 - Closed. Currency in DKK ( Disclaimer )
  • Volume: 163,163
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 1,081.20 - 1,081.20
Type:  Equity
Market:  United Kingdom
ISIN:  DK0060534915 
SEDOL:  BHY3360
Novo Nordisk B 1,081.20 +9.60 +0.90%

0QIU Cash Flow Statement

 
Featured here, the Cash Flow Statement for Novo Nordisk A/S Class B, showing the changes in the company's cash and cash equivalents, broken down to operating, investing and financing activities over each of the last 4 periods (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Cash Flow Statement
Collapse All
Period Ending: 2022
31/12
 2022
30/09
 2022
30/06
 2022
31/03
Period Length: 0 Months 0 Months 0 Months 0 Months
Net Income/Starting Line 13592 14405 13318 14210
Cash From Operating Activities 7101 24239 23961 23586
Depreciation/Depletion 1031 2041 1636 1650
Amortization - - - -
Deferred Taxes -4631 - - -
Non-Cash Items -7409 18803 4918 5833
Cash Receipts - - - -
Cash Payments - - - -
Cash Taxes Paid 4587 1699 2969 5260
Cash Interest Paid 86 66 68 52
Changes in Working Capital -308 -11010 4089 1893
Cash From Investing Activities -13850 -4961 -4200 -1907
Capital Expenditures -4961 -3230 -2435 -1520
Other Investing Cash Flow Items, Total -8889 -1731 -1765 -387
Cash From Financing Activities -7668 -14563 -10431 -19135
Financing Cash Flow Items - - -2737 2737
Total Cash Dividends Paid - -9613 - -15690
Issuance (Retirement) of Stock, Net -7539 -4620 -7450 -4477
Issuance (Retirement) of Debt, Net -129 -330 -244 -1705
Foreign Exchange Effects -757 - - -777
Net Change in Cash -15261 5158 9548 2489
Beginning Cash Balance 27914 23307 13210 10905
Ending Cash Balance 12653 28465 22758 13394
Free Cash Flow -4019 20389 19197.38 21929.88
Free Cash Flow Growth -119.71 6.21 -12.46 580.63
Free Cash Flow Yield 0.044 1.16 1.2 1.28
* In Millions of (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the cash flow statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

NOVOb Comments

Write your thoughts about Novo Nordisk L
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email